Personal information

Websites & social links

http://www.ieos.cnr.it/personale/index.php?id=1422872552

Countries

Italy

Activities

Collapse all

Employment (6)

Italian National Council of Research: Napoli, IT

2019-12 to present | First Researcher (Institute for the Experimental Endocrinology and Oncology “G. Salvatore”)
Employment
Source: Self-asserted source
Roberta Visconti

Italian National Council of Research: Napoli, IT

2001-12 to 2019-11 | Researcher (Institute for the Experimental Endocrinology and Oncology “G. Salvatore”)
Employment
Source: Self-asserted source
Roberta Visconti

University of Napoli “Federico II”: Napoli, IT

2000 to 2001 | Fellow
Employment
Source: Self-asserted source
Roberta Visconti

National Institutes of Health: Bethesda, MD, US

1998 to 2000 | Visiting Fellow (National Institute of Arthritis and Musculoskeletal and Skin Diseases)
Employment
Source: Self-asserted source
Roberta Visconti

University of Napoli “Federico II”: Napoli, IT

1995 to 1999 | Ph.D. student (Department of Cellular and Molecular Biology and Pathology)
Employment
Source: Self-asserted source
Roberta Visconti

University of Napoli “Federico II”: Napoli, IT

1991 to 1994 | Pre-doctoral Fellow (Department of Cellular and Molecular Biology and Pathology)
Employment
Source: Self-asserted source
Roberta Visconti

Education and qualifications (2)

University of Napoli “Federico II”: Napoli, IT

2000 to 2000 | Ph.D.
Education
Source: Self-asserted source
Roberta Visconti

University of Napoli “Federico II”: Napoli, IT

1994 to 1994 | Medical Doctor
Education
Source: Self-asserted source
Roberta Visconti

Professional activities (1)

National Institutes of Health: Bethesda, MD, US

2000 | Fellow Award for Research Excellence
Distinction
Source: Self-asserted source
Roberta Visconti

Funding (18)

OPADE: Optimise and predict antidepressant efficacy for patient with major depressive disorders using multi-omics analysis and AI-predictive tool

2023 to 2028 | Grant
Horizon 2020 (Bruxelles, BE)
Source: Self-asserted source
Roberta Visconti

Defining the role of the lysine methyltransferase SETD8 as a novel epigenetic target for the therapy of glioblastomas

2022 to 2024 | Grant
Ministero dell'Università e della Ricerca (Rome, IT)
Source: Self-asserted source
Roberta Visconti

Ovarian cancer cells: from iron addiction to ferroptosis vulnerability

2022 to 2024 | Grant
Ministero dell'Università e della Ricerca (Rome, IT)
Source: Self-asserted source
Roberta Visconti

Exploiting PARP-modulating enzymes in ovarian cancer therapy

2021 to 2023 | Grant
Ovarian Cancer Research Alliance (New York, New York, US)
Source: Self-asserted source
Roberta Visconti

RECOVER-COVID 19 (RicErCa e sviluppO VERsus COVID19 in Campania)

2020 to 2020 | Grant
Regione Campania (Naples, IT)
Source: Self-asserted source
Roberta Visconti

Innovative devices for shaping the risk of diabetes

2019 to 2022 | Grant
Ministero dell'Università e della Ricerca (Rome, IT)
Source: Self-asserted source
Roberta Visconti

Valutazione di mediatori stromali con effetto pro-tumorigenico nei carcinomi del colon

2018 to 2019 | Grant
Regione Campania (Napoli, IT)
Source: Self-asserted source
Roberta Visconti

Unveiling new layers of regulation for mitotic progression and their relevance in cancer

2017 to 2021 | Grant
Associazione Italiana per la Ricerca sul Cancro (Milano, IT)
Source: Self-asserted source
Roberta Visconti

Deconstructing mitosis: a phosphatase cascade controlling ordered mitosis exit and its exploitability for cancer therapy

2014 to 2016 | Grant
Associazione Italiana per la Ricerca sul Cancro (Milano, IT)
Source: Self-asserted source
Roberta Visconti

Ensuring coordinated chromosome segregation: mechanisms for spindle assembly checkpoint silencing

2011 to 2013 | Grant
Associazione Italiana per la Ricerca sul Cancro (Milano, IT)
Source: Self-asserted source
Roberta Visconti

Processes and mechanisms controlling genome integrity

2010 to 2011 | Grant
Ministero dell’Istruzione, dell’Università e della Ricerca (Roma, IT)
Source: Self-asserted source
Roberta Visconti

Development of a platform technology for the evaluation of anti-inflammatory and anti-neoplstic drugs by using cellular and animal models

2008-09 to 2010-08 | Grant
Ministero dell’Istruzione, dell’Università e della Ricerca (Roma, IT)
Source: Self-asserted source
Roberta Visconti

Coordinating proteolysis with mitotic spindle assembly: mechanisms for chromosomal stability

2008 to 2010 | Grant
Associazione Italiana per la Ricerca sul Cancro (Milano, IT)
Source: Self-asserted source
Roberta Visconti

Monoclonal antibodies and peptides against moleculat targets involved in the pathogenetic mechanisms of neoplastic and degenerative diseases

2008 to 2009 | Grant
Ministero dell’Istruzione, dell’Università e della Ricerca (Roma, IT)
Source: Self-asserted source
Roberta Visconti

Role of the HMGA proteins in differentiation and carcinogenesis

2006 to 2006 | Grant
Associazione Italiana per la Ricerca sul Cancro (Milano, IT)
Source: Self-asserted source
Roberta Visconti

Tecnological-industrial transfer of the structural and functional genomic of superior organisms

2004 to 2005 | Grant
Regione Campania (Napoli, IT)
Source: Self-asserted source
Roberta Visconti

Identification and characterization of genes involved in thyroid neoplastic transformation

2002 to 2002 | Grant
Regione Campania (Napoli, IT)
Source: Self-asserted source
Roberta Visconti

Tecnological-industrial transfer of the structural and functional genomic of superior organisms

2002 to 2002 | Grant
Regione Campania (Napoli, IT)
Source: Self-asserted source
Roberta Visconti

Works (50 of 61)

Items per page:
Page 1 of 2

Targeted inhibition of the methyltransferase SETD8 synergizes with the Wee1 inhibitor adavosertib in restraining glioblastoma growth

Cell Death & Disease
2023 | Journal article
DOI: 10.1038/s41419-023-06167-3
Source: Self-asserted source
Roberta Visconti

A Rare Adult Primary Intracranial Sarcoma, <i>DICER1</i>-Mutant Identified by Epigenomic Profiling: A Case Report

Brain Sciences
2023-01 | Journal article | Author
DOI: 10.3390/brainsci13020235
Contributors: Alfredo Marinelli; Mariella Cuomo; Raduan Ahmed Franca; Michela Buonaiuto; Davide Costabile; Cristina Pagano; Federica Trio; Liliana Montella; Marialaura Del Basso De Caro; Roberta Visconti et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Methylome Profiling in Fabry Disease in Clinical Practice: A Proof of Concept

International Journal of Molecular Sciences
2022-10 | Journal article | Author
DOI: 10.3390/ijms232012110
Contributors: Teodolinda Di Risi; Mariella Cuomo; Roberta Vinciguerra; Sara Ferraro; Rosa Della Monica; Davide Costabile; Michela Buonaiuto; Federica Trio; Ettore Capoluongo; Roberta Visconti et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

MGMT and Whole-Genome DNA Methylation Impacts on Diagnosis, Prognosis and Therapy of Glioblastoma Multiforme

International Journal of Molecular Sciences
2022-06 | Journal article | Author
DOI: 10.3390/ijms23137148
Contributors: Rosa Della Monica; Mariella Cuomo; Michela Buonaiuto; Davide Costabile; Raduan Ahmed Franca; Marialaura Del Basso De Caro; Giuseppe Catapano; Lorenzo Chiariotti; Roberta Visconti
Source: check_circle
Multidisciplinary Digital Publishing Institute

Evaluation of MGMT Gene Methylation in Neuroendocrine Neoplasms

Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
2022-01-31 | Journal article
DOI: 10.3727/096504021x16214197880808
Part of ISSN: 0965-0407
Source: Self-asserted source
Roberta Visconti

Exploiting immune-dependent effects of microtubule-targeting agents to improve efficacy and tolerability of cancer treatment

Cell Death & Disease
2020-05 | Journal article
DOI: 10.1038/s41419-020-2567-0
Part of ISSN: 2041-4889
Source: Self-asserted source
Roberta Visconti

CCDC6 and USP7 expression levels suggest novel treatment options in high-grade urothelial bladder cancer

Journal of Experimental & Clinical Cancer Research
2019-12 | Journal article
DOI: 10.1186/s13046-019-1087-1
Part of ISSN: 1756-9966
Source: Self-asserted source
Roberta Visconti

New combinatorial strategies to improve the PARP inhibitors efficacy in the urothelial bladder Cancer treatment

Journal of Experimental & Clinical Cancer Research
2019-12 | Journal article
DOI: 10.1186/s13046-019-1089-z
Part of ISSN: 1756-9966
Source: Self-asserted source
Roberta Visconti

Analysis of CCDC6 as a novel biomarker for the clinical use of PARP1 inhibitors in malignant pleural mesothelioma

Lung Cancer
2019-09 | Journal article
DOI: 10.1016/j.lungcan.2019.07.011
Part of ISSN: 0169-5002
Source: Self-asserted source
Roberta Visconti

Wee1 Rather Than Plk1 Is Inhibited by AZD1775 at Therapeutically Relevant Concentrations

Cancers
2019-06-13 | Journal article
DOI: 10.3390/cancers11060819
Part of ISSN: 2072-6694
Source: Self-asserted source
Roberta Visconti

The rationale for druggability of CCDC6-tyrosine kinase fusions in lung cancer

Molecular Cancer
2018-12 | Journal article
DOI: 10.1186/s12943-018-0799-8
Part of ISSN: 1476-4598
Source: Self-asserted source
Roberta Visconti

Evidence that PP2A activity is dispensable for spindle assembly checkpoint-dependent control of Cdk1

Oncotarget
2018-01-26 | Journal article
DOI: 10.18632/oncotarget.23329
Part of ISSN: 1949-2553
Source: Self-asserted source
Roberta Visconti

Fighting tubulin-targeting anticancer drug toxicity and resistance

Endocrine-Related Cancer
2017 | Journal article
DOI: 10.1530/ERC-17-0120
Source: Self-asserted source
Roberta Visconti

The between now and then of lung cancer chemotherapy and immunotherapy

International Journal of Molecular Sciences
2017 | Journal article
DOI: 10.3390/ijms18071374
Source: Self-asserted source
Roberta Visconti
grade
Preferred source (of 2)‎

USP7 inhibitors, downregulating CCDC6, sensitize lung neuroendocrine cancer cells to PARP-inhibitor drugs

Lung Cancer
2017 | Journal article
DOI: 10.1016/j.lungcan.2016.06.015
Source: Self-asserted source
Roberta Visconti

Cell cycle checkpoint in cancer: a therapeutically targetable double-edged sword

Journal of Experimental & Clinical Cancer Research
2016 | Journal article
DOI: 10.1186/s13046-016-0433-9
Source: Self-asserted source
Roberta Visconti

Sustaining the Spindle Assembly Checkpoint to improve cancer therapy

Molecular and Cellular Oncology
2016 | Journal article
DOI: 10.1080/23723556.2015.1046583
Source: Self-asserted source
Roberta Visconti

The Fcp1-Wee1-Cdk1 axis affects spindle assembly checkpoint robustness and sensitivity to anti-microtubule cancer drugs

Cell Death and Differentiation
2016 | Journal article
DOI: 10.1038/cdd.2015.13
Source: Self-asserted source
Roberta Visconti

FBXW7 and USP7 regulate CCDC6 turnover during the cell cycle and affect cancer drugs susceptibility in NSCLC

Oncotarget
2015 | Journal article
DOI: 10.18632/oncotarget.3708
Source: Self-asserted source
Roberta Visconti

Fcp1 phosphatase controls Greatwall kinase to promote PP2A-B55 activation and mitotic progression

eLife
2015 | Journal article
DOI: 10.7554/eLife.10399
Source: Self-asserted source
Roberta Visconti

New therapeutic perspectives in CCDC6 deficient lung cancer cells

International Journal of Cancer
2015 | Journal article
DOI: 10.1002/ijc.29263
Source: Self-asserted source
Roberta Visconti

ATM controls proper mitotic spindle structure

Cell Cycle
2014 | Journal article
DOI: 10.4161/cc.27945
Source: Self-asserted source
Roberta Visconti

The end of mitosis from a phosphatase perspective

Cell Cycle
2013 | Journal article
DOI: 10.4161/cc.22875
Source: Self-asserted source
Roberta Visconti

Fcp-1 dependent dephosphorylation is required for M-phase-promoting factor inactivation at mitosis exit

Nature Communications
2012 | Journal article
DOI: 10.1038/ncomms1886
Source: Self-asserted source
Roberta Visconti

Requirement for proteolysis in spindle assembly checkpoint silencing

Cell Cycle
2010 | Journal article
DOI: 10.4161/cc.9.3.10581
Source: Self-asserted source
Roberta Visconti

New insights on oxidative stress in cancer

Current Opinion in Drug Discovery and Development
2009 | Journal article
PMID: 19333869
Source: Self-asserted source
Roberta Visconti

Functional cloning of genes regulating apoptosis in neuronal cells

Neuroprotection methods and protocols
2007 | Book chapter
DOI: 10.1007/978-1-59745-504-6_9
Source: Self-asserted source
Roberta Visconti

Retrospective analysis of coagulation factor II receptor (F2R) sequence variation and coronary heart disease in hypertensive patients

Arteriosclerosis, Thrombosis, and Vascular Biology
2007 | Journal article
DOI: 10.1161/ATVBAHA.107.140541
Source: Self-asserted source
Roberta Visconti

Transcriptional profile of Ki-Ras-induced transformation of thyroid cells

Cancer Investigation
2007 | Journal article
DOI: 10.1080/07357900701206406
Source: Self-asserted source
Roberta Visconti

Characterization and analysis of the proximal Janus kinase 3 promoter

The Journal of Immunology
2003 | Journal article
DOI: 10.4049/jimmunol.170.12.6057
Source: Self-asserted source
Roberta Visconti

Cloning and molecular characterization of a novel gene strongly induced by the adenovirus E1A gene in rat thyroid cells

Oncogene
2003 | Journal article
DOI: 10.1038/sj.onc.1206194
Source: Self-asserted source
Roberta Visconti

Molecular basis of severe combined immunodeficiency: lessons from cytokine signaling pathways

Signal transduction and human disease
2003 | Book chapter
ISBN: 0-471-02011-7
Source: Self-asserted source
Roberta Visconti

The platelet-derived growth factor controls c-myc expression through a JNK- and AP-1-dependent signaling pathway.

The Journal of Biological Chemistry
2003 | Journal article
DOI: 10.1074/jbc.M308617200
Source: Self-asserted source
Roberta Visconti

Molecular aspects of primary immunodeficiencies: lessons from cytokine and other signaling pathways

Journal of Clinical Investigation
2002 | Journal article
DOI: 10.1172/JCI15769
Source: Self-asserted source
Roberta Visconti

Positive effects of glucocorticoids on T cell function by up-regulation of IL-7 receptor alpha

The Journal of Immunology
2002 | Journal article
DOI: 10.4049/jimmunol.168.5.2212
Source: Self-asserted source
Roberta Visconti

STAT4 serine phosphorylation is critical for IL-12-induced IFN-gamma production but not for cell proliferation

Proceedings of the National Academy of Sciences of the United States of America
2002 | Journal article
DOI: 10.1073/pnas.182618999
Source: Self-asserted source
Roberta Visconti

Increased in vivo phosphorylation of ret tyrosine 1062 is a potential pathogenetic mechanism of multiple endocrine neoplasia type 2B

Cancer Research
2001 | Journal article
PMID: 11245446
Source: Self-asserted source
Roberta Visconti

Janus kinases and STAT family transcription factors: their role in the function and development of lymphoid cells

Transcription factors: normal and malignant development of blood cells
2001 | Book chapter
ISBN: 0-471-35054-0
Source: Self-asserted source
Roberta Visconti

Signaling by Type I and II cytokine receptors: ten years after

Current Opinion in Immunology
2001 | Journal article
DOI: 10.1016/S0952-7915(00)00228-4
Source: Self-asserted source
Roberta Visconti

The RFG oligomerization domain mediates kinase activation and re-localization of the RET/PTC3 oncoprotein to the plasma membrane

Oncogene
2001 | Journal article
DOI: 10.1038/sj.onc.1204127
Source: Self-asserted source
Roberta Visconti

Akt/Protein Kinase B promotes survival and hormone-independent proliferation of thyroid cells in the absence of dedifferentiating and transforming effects

Cancer Research
2000 | Journal article
PMID: 10919669
Source: Self-asserted source
Roberta Visconti

Importance of the MKK6/p38 pathway for interleukin-12-induced STAT4 serine phosphorylation and transcriptional activity

Blood
2000 | Journal article
PMID: 10961885
Source: Self-asserted source
Roberta Visconti

Inhibition of Th1 immune response by glucocorticoids: Dexamethasone selectively inhibits IL-12-induced Stat4 phosphorylation in T lymphocytes

The Journal of Immunology
2000 | Journal article
DOI: 10.4049/jimmunol.164.4.1768
Source: Self-asserted source
Roberta Visconti

Jaks and Stats as therapeutic targets

Annals of the Rheumatic Diseases
2000 | Journal article
ETHOS: 10.1136/ard.59.suppl_1.i115
Source: Self-asserted source
Roberta Visconti

Janus kinases and signal transducers and activators of transcription: their roles in cytokine signaling, development and immunoregulation

Arthritis Research and Therapy
2000 | Journal article
DOI: 10.1186/ar66
Source: Self-asserted source
Roberta Visconti

The docking molecule Gab2 is induced by lymphocyte activation and is involved in signaling by Interleukin-2 and Interleukin-15 but not other common gamma chain-using cytokines

The Journal of Biological Chemistry
2000 | Journal article
DOI: 10.1074/jbc.M004021200
Source: Self-asserted source
Roberta Visconti

The highly malignant phenotype of anaplastic thyroid carcinoma cell lines is recessive

European Journal of Endocrinology
2000 | Journal article
PMID: 11022199
Source: Self-asserted source
Roberta Visconti

Type I IFNs and regulation of Th1 responses: enigmas both resolved and emerge

Nature Immunology
2000 | Journal article
DOI: 10.1038/76872
Source: Self-asserted source
Roberta Visconti

Tyrosine 1062 of RET-MEN2A mediates activation of Akt (protein kinase B) and mitogen-activated protein kinase pathways leading to PC12 cell survival

Cancer Research
2000 | Journal article
PMID: 10919641
Source: Self-asserted source
Roberta Visconti

Different mutations of the RET gene cause different human tumoral diseases

Biochimie
1999 | Journal article
DOI: 10.1016/S0300-9084(99)80087-X
Source: Self-asserted source
Roberta Visconti
Items per page:
Page 1 of 2

Peer review (6 reviews for 4 publications/grants)

Review activity for Cancer letters. (1)
Review activity for Cancers. (1)
Review activity for Cell death and disease. (3)
Review activity for Journal of experimental & clinical cancer research. (1)
How many people are using ORCID?